Zhenji Capital

Zhenji Capital is a Chinese private equity firm specializing in late-stage investments in biotechnology and pharmaceutical sectors. The firm focuses on companies with disruptive potential in these industries, aiming to accelerate their growth and scalability. Zhenji Capital provides strategic capital and operational expertise to help portfolio companies achieve sustainable success.

The firm's investment strategy emphasizes a hands-on approach, combining strategic capital with deep industry expertise to build resilient businesses that create long-term value and impact. Zhenji Capital partners with visionary entrepreneurs to build transformative companies across biotechnology, pharmaceuticals, and therapeutics sectors.

Zhenji Capital's portfolio includes investments in companies such as IMPACT Therapeutics, a biotechnology firm specializing in cancer therapeutics. The firm is committed to fostering innovation and driving growth in the biotechnology and pharmaceutical industries, contributing to the advancement of healthcare solutions in China.